<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30247968</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1557-7708</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>24</Volume>                    <Issue>9-10</Issue>                    <PubDate>                        <MedlineDate>2018 Sep/Oct</MedlineDate>                    </PubDate>                </JournalIssue>                <Title>Journal of alternative and complementary medicine (New York, N.Y.)</Title>                <ISOAbbreviation>J Altern Complement Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy.</ArticleTitle>            <Pagination>                <MedlinePgn>933-941</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1089/acm.2018.0143</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To address the side effects of anticancer treatments, the Clinic for Complementary Medicine and Diet in Oncology was opened, in collaboration with the oncology department, at the Hospital of Lucca (Italy) in 2013.</AbstractText>                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To present the results of complementary medicine treatment targeted toward reducing the adverse effects of anticancer therapy and cancer symptoms, and improving patient quality of life. Dietary advice was aimed at the reduction of foods that promote inflammation in favor of those with antioxidant and anti-inflammatory properties.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective observational study on 357 patients consecutively visited from September 2013 to December 2017. The intensity of symptoms was evaluated according to a grading system from G0 (absent) to G1 (slight), G2 (moderate), and G3 (strong). The severity of radiodermatitis was evaluated with the Radiation Therapy Oncology Group (RTOG) scale. Almost all the patients (91.6%) were receiving or had just finished some form of conventional anticancer therapy.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The main types of cancer were breast (57.1%), colon (7.3%), lung (5.0%), ovary (3.9%), stomach (2.5%), prostate (2.2%), and uterus (2.5%). Comparison of clinical conditions before and after treatment showed a significant amelioration of nausea, insomnia, depression, anxiety, fatigue, mucositis, hot flashes, joint pain, dysgeusia, neuropathy, and all symptoms. Moreover, in a subgroup of 17 patients in radiotherapy undergoing integrative treatment, the level of toxicities and the severity of radiodermatitis were much lower than in the 13 patients without integrative treatment. Twenty-one cancer patients (6.2%) either refused (18) or discontinued (3) conventional anticancer treatment against the recommendation of their oncologist; after the integrative oncology (IO) visit, 7 (41.2%) out of 17 patients with follow-up decided to accept standard oncologic treatments.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">An IO clinic may contribute to reducing the adverse effects of anticancer therapy and improving the quality of life of cancer patients.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Rossi</LastName>                    <ForeName>Elio</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy .</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Noberasco</LastName>                    <ForeName>Cristina</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy .</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Picchi</LastName>                    <ForeName>Marco</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy .</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Stefano</LastName>                    <ForeName>Mariella Di</ForeName>                    <Initials>MD</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy .</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rossi</LastName>                    <ForeName>Antonella</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy .</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nurra</LastName>                    <ForeName>Linda</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Complementary Medicine , ASL Tuscany North West, Lucca, Italy .</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ventura</LastName>                    <ForeName>Leonardo</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>2 ISPRO, Oncological Network, Prevention and Research Institute , Firenze, Italy .</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D064888">Observational Study</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Altern Complement Med</MedlineTA>            <NlmUniqueID>9508124</NlmUniqueID>            <ISSNLinking>1075-5535</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000970" MajorTopicYN="Y">Antineoplastic Agents</DescriptorName>                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000529" MajorTopicYN="N">Complementary Therapies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D064420" MajorTopicYN="N">Drug-Related Side Effects and Adverse Reactions</DescriptorName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055048" MajorTopicYN="Y">Integrative Medicine</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000073196" MajorTopicYN="Y">Integrative Oncology</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>                <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">anticancer diet</Keyword>            <Keyword MajorTopicYN="N">anticancer therapy</Keyword>            <Keyword MajorTopicYN="N">cancer patients</Keyword>            <Keyword MajorTopicYN="N">complementary and integrative medicine</Keyword>            <Keyword MajorTopicYN="N">integrative oncology</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>25</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>16</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30247968</ArticleId>            <ArticleId IdType="doi">10.1089/acm.2018.0143</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>